AMANDA SPICER: Open Payments
NPI 1053880948 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,240 in 60 payments from 18 companies in 2025. Trend: 2023 $750 · 2024 $1,386 · 2025 $1,240
Food & beverage: $1,240
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $230 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $160 |
| Axsome Therapeutics, Inc. | 7 | $149 |
| Janssen Pharmaceuticals, Inc | 6 | $127 |
| Neurocrine BioSciences, Inc. | 6 | $124 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| ABBVIE INC. | 3 | $63 |
| Lundbeck LLC | 3 | $61 |
| E.R. Squibb & Sons, L.L.C. | 1 | $48 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
Products named: CAPLYTA, Auvelity, ARISTADA, REXULTI, INGREZZA, LYBALVI, SPRAVATO, VRAYLAR.
Industry payments across OH — which companies pay providers there.
